Whitney Lewis

Title: Innovations of Whitney Lewis in Genetic Engineering

Introduction

Whitney Lewis is a notable inventor based in Oxford, NC (US), recognized for his contributions to genetic engineering. With a total of three patents, Lewis has made significant strides in the field, particularly in the development of engineered meganucleases.

Latest Patents

One of his latest patents involves polynucleotides encoding engineered meganucleases that have specificity for recognition sequences in the dystrophin gene. This patent encompasses engineered meganucleases that bind and cleave recognition sequences within the dystrophin gene. The disclosure also includes methods for using these engineered meganucleases to create genetically modified cells. Furthermore, it covers pharmaceutical compositions comprising engineered meganuclease proteins or polynucleotides encoding these meganucleases, aimed at modifying the dystrophin gene in subjects or treating Duchenne Muscular Dystrophy.

Career Highlights

Whitney Lewis is currently associated with Precision Biosciences, Inc., where he continues to innovate in the realm of genetic research and development. His work focuses on advancing therapeutic options for genetic disorders, showcasing his commitment to improving patient outcomes through scientific innovation.

Collaborations

Lewis collaborates with esteemed colleagues, including Gary Owens and Janel Lape, who contribute to his research endeavors and help drive forward the mission of Precision Biosciences, Inc.

Conclusion

Whitney Lewis stands out as a pioneering inventor in genetic engineering, with a focus on developing solutions for serious genetic conditions. His work not only reflects his innovative spirit but also holds the potential to transform the landscape of genetic therapies.